Skip to main content
Clinical Trials/NCT00136500
NCT00136500
Recruiting
Not Applicable

Clinical Research in Amyotrophic Lateral Sclerosis

University of Miami1 site in 1 country10,000 target enrollmentFebruary 1, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amyotrophic Lateral Sclerosis
Sponsor
University of Miami
Enrollment
10000
Locations
1
Primary Endpoint
Recruitment
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).

Detailed Description

Research goals include elucidation of the complex relationship between ALS and related neurodegenerative disorders, development of both wet and dry biomarkers of disease, and delineation of the full course of the natural history of disease from the early pre-symptomatic stages through established and even late-stage disease. These goals are accomplished through the recruitment and evaluation of patients with ALS and related diseases, family members (including people at genetic risk for ALS, but who are not yet affected), and healthy controls.

Registry
clinicaltrials.gov
Start Date
February 1, 2005
End Date
December 1, 2037
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Benatar

Professor

University of Miami

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age.
  • Member of at least one of the following categories:
  • Individuals affected with ALS or a related neurodegenerative disease (sporadic or familial)
  • Unaffected individuals from fALS pedigrees, including pre-symptomatic individuals at genetic risk for ALS or individuals from pedigrees of ALS related diseases.
  • Healthy controls
  • Able and willing to comply with relevant procedures.

Exclusion Criteria

  • 1\. Subject has a condition or is in a situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol -- including but not limited to neurological, psychological and/or medical conditions (e.g., multiple sclerosis, neuropathy, myelopathy).

Outcomes

Primary Outcomes

Recruitment

Time Frame: Annually

Since this is an umbrella/gateway protocol through which individuals are recruited to participate in a range of studies, outcome is assessed in terms of recruitment.

Study Sites (1)

Loading locations...

Similar Trials